Abstract

Effective HIV transmission prevention strategies have led to a growing population of vulnerable HIV- and antiretroviral-exposed infants in sub-Saharan Africa, however uncertainty exists regarding their development. To determine the developmental outcomes of HIV-exposed (HE) infants in a low-income South African context, when compared to HIV-unexposed (HU) counterparts. In this prospective cross-sectional, group comparison study, the development of 41 HE and 40 HU infants (mean age=8.4 months, SD=2.1 months) from a low-income context was assessed. Caregivers were interviewed using the Vineland Adaptive Behavior Scales, Third Edition (Vineland-3) to evaluate infants' development. Most HE participants had age-appropriate overall development (90.2%;n=37). Some HE participants, however, presented with delays in domains of communication (9.8%;n=4), daily living skills (2.4%;n=1), socialisation (19.5%;n=8), and motor development (7.3%;n=3). HU participants also demonstrated some domain-specific delays, thus delays were present in both groups. No statistically significant between-group differences regarding development were found. Findings were reassuring and suggested that HE and HU participants had similar development. Developmental differences may, however, only emerge with age, therefore large-scale longitudinal research is recommended. It is suggested that the entire sample was vulnerable, highlighting the importance of developmental surveillance in low-income contexts, irrespective of HIV and antiretroviral exposure status.

Highlights

  • 37.9 million people are living with Human Immunodeficiency Virus (HIV) worldwide, of which 20.3% reside in South Africa, a lower-middle-income country in sub-Saharan Africa[1]

  • HU participants demonstrated some domain-specific delays, delays were present in both groups

  • Developmental differences may, only emerge with age, large-scale longitudinal research is recommended

Read more

Summary

Introduction

37.9 million people are living with Human Immunodeficiency Virus (HIV) worldwide, of which 20.3% reside in South Africa, a lower-middle-income country in sub-Saharan Africa[1]. African Health Sciences, Vol 20 Issue 4, December, 2020 brain development[4], and it has been reported that ARV exposure could be associated with preterm birth and mitochondrial dysfunction, resulting in neurological and developmental problems[5]. It is suggested, that ARVs are safe to use during pregnancy and the perinatal period[3] and that ante- and postpartum combination ARV exposure has no adverse effects on infant and child development[4,6]. Objective: To determine the developmental outcomes of HIV-exposed (HE) infants in a low-income South African context, when compared to HIV-unexposed (HU) counterparts. Developmental outcomes of HIV-exposed infants in a low-income South African context.

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call